Patent 9284543 was granted and assigned to Halozyme, Inc. on March, 2016 by the United States Patent and Trademark Office.
Soluble PH20 polypeptides are provided, including extended soluble PH20 polypeptides, and uses thereof. Also provided are other C-terminally truncated PH20 polypeptides and partially deglycosylated PH20 polypeptides and uses thereof.